(1 - 8 von 27
)
Frost & Sullivan: New Drug Candidates Hold Tremendous Promise for...
www.finanznachrichten.de
- Patients to benefit from potential for improved efficacy in less commonly used types of ARV therapies and one-pill-daily combination drugs LONDON, April...
European monoclonal antibody market set to hit $42bn by PMLiVE
www.pmlive.com
· Frost & Sullivan research analyst Deepika Pramod Chopda said: “Technological development within the biotech and genomic markets triggered ...
Latest News - Cypriot Biotech Database
www.cypriotbiotech.com
... new drug candidates over the last decade have spurred the HIV drugs market," notes Frost & Sullivan Healthcare Research Analyst Deepika Pramod Chopda.
March 27 th March 27 th Market Dynamics Surrounding ...
richmedia.decisionnewsmedia.com
March 27 th March 27 th Market Dynamics Surrounding Bioavailability Deepika Pramod Chopda Research Analyst - Life Sciences Frost & Sullivan ...
sortiert nach Relevanz / Datum